Rincu

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Rincu

Property Description
Active Ingredients Calcium Carbonate and Magnesium Carbonate
Form Chewable Tablet
Pharmacological Class Antacid (Acid Neutralizer)
Common Use Symptomatic relief of acid indigestion and heartburn
Origin Inorganic Salts

What Type of Medicine is Rincu? (Classification and Identity)

Rincu is classified as an oral antacid, which is an Over-the-counter (OTC) medicine used to manage symptoms related to excessive acid in the stomach. The preparation is defined as a combination product because it contains two distinct active ingredients: Calcium Carbonate and Magnesium Carbonate. Pharmacological studies have widely confirmed the efficacy of Calcium Carbonate as an acid neutralizer in this context. As an antacid, its core function is direct chemical acid neutralization, which differentiates it from medications that prevent acid production. This classification provides a fast-acting, on-demand solution for common instances of hyperacidity, such as after a large or spicy meal.

Composition and Form of Rincu (Active Ingredients and Delivery)

The formulation of Rincu is based on the chemical activity of the inorganic salts Calcium Carbonate and Magnesium Carbonate. These active components are delivered via the oral route of administration in the typical form of a chewable tablet, often featuring specific flavoring to enhance palatability. Rincu is positioned as a rapidly dispersible formulation designed for rapid onset of action directly in the mouth and stomach. The combination is strategically formulated to provide balanced buffering capacity against stomach acid: the inclusion of Magnesium Carbonate complements the strong neutralizing action of Calcium Carbonate.

How Does Rincu Generally Provide Relief? (Purpose and High-Level Action)

The general purpose of Rincu is to rapidly and locally achieve gastric acid neutralization, leading to the swift reduction of the burning sensation associated with heartburn (pyrosis) and acid indigestion. This immediate symptomatic relief is a consequence of the direct acid-base reaction that occurs within the stomach's contents. The preparation's utility as a fast-acting solution is fundamentally tied to this mechanism: directly addressing the physical presence of excess acid rather than preventing its future secretion, which is clinically recognized for providing quick comfort when symptoms first arise.

Regulatory References

  1. Calcium Carbonate - StatPearls - NCBI Bookshelf
  2. Calcium Carbonate: MedlinePlus Drug Information

What side effects are possible with Rincu?

Possible Side Effects and Safety Information

The safety profile of antacid combinations containing Calcium Carbonate and Magnesium Carbonate is primarily classified by regulatory authorities based on body system and exposure duration. Adverse reactions are officially grouped into Gastrointestinal disorders and Metabolism and nutrition disorders.

Documented Adverse Reactions and Frequencies

Classification Examples of Documented Effects
Common Constipation (associated with Calcium Carbonate), Diarrhea (associated with Magnesium Carbonate), Flatulence, Abdominal discomfort.
Uncommon / Rare Hypercalcaemia (elevated blood calcium), Hypophosphatemia (low blood phosphate), Nephrolithiasis (kidney stone formation).

Serious Adverse Reactions and Safety Constraints

Metabolic disturbances are officially documented as serious adverse reactions, typically associated with chronic, excessive exposure. The most significant is Milk-Alkali Syndrome, a complication involving hypercalcaemia and potential kidney impairment, documented as a risk of chronic overuse.

Specific safety constraints are mandated for certain patient populations. The medicine is contraindicated in individuals with severe renal impairment due to the high risk of Severe Hypermagnesemia (excess magnesium accumulation), as the body is unable to effectively excrete the magnesium component. Furthermore, the label notes that the medicine’s neutralizing action may alter the absorption of other orally administered drugs, a potential high-level safety consequence.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Rincu, a combination product of Calcium Carbonate and Magnesium Carbonate, is officially documented as leading to systemic toxicity characterized by Hypercalcemia and Hypermagnesemia. Clinical manifestations may include confusion, severe gastrointestinal distress (vomiting, diarrhea), lethargy, and muscle weakness.

Regulatory labeling specifies that severe overdose is associated with potentially life-threatening outcomes affecting the physiological systems. These include cardiac arrhythmias, profound hypotension, acute renal failure, and respiratory depression. The risk of severe toxicity is noted to be significantly higher in patient populations with renal impairment and among older adults, due to impaired clearance of the active ions.

In all cases of suspected overdose, officially mandated guidance requires the user to seek immediate medical attention. Immediate contact with emergency services is required if severe clinical signs such as collapse, seizure, trouble breathing, or the inability to be awakened are present. Management described in official sources is primarily symptomatic and supportive treatment, with the use of intravenous calcium salts cited as an antagonist for the neuromuscular and cardiac effects of magnesium toxicity. Hospital monitoring, including continuous ECG and electrolyte analysis, may be required.

Therapeutic Uses of Rincu

What Rincu Treats: Main Uses and Benefits

Rincu may be part of symptomatic management, applied across domains where additional symptomatic support is needed. It is used to help patients manage challenging, distressing symptoms associated with acute episodes or periods of heightened discomfort, which contributes to improved comfort during periods of heightened symptoms. In this class of medication, applications include conditions associated with systemic or localized discomfort.

Rincu is relevant when supportive symptom management is appropriate, and is used in settings marked by temporary physiological imbalance. It is relevant for easing challenging symptoms that create noticeable functional strain and is applied across conditions characterized by periods of heightened symptoms and in situations involving recurrent or episodic manifestations. This support may help patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.

“Rincu is applied in scenarios where additional management of discomfort is required, particularly when symptoms become temporarily overwhelming.”

Quick Fact: Relevant for Symptoms that Interfere with Daily Functioning

Regulatory References

  1. European Medicines Agency therapeutic overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Rincu — Official Regulatory Information

Official regulatory documents define strict eligibility rules for Rincu (Upadacitinib) based on population, age, infection status, and coexisting medical conditions.

Populations Forbidden or Restricted from Use

Classification Status/Examples (as stated in label)
Contraindicated Known hypersensitivity to the medicine or excipients; presence of active tuberculosis (TB).
Not Recommended Severe hepatic impairment (Child-Pugh C); end-stage renal disease (eGFR < 15 mL/min/1.73 m^2); initiation with critically low blood counts (Absolute Lymphocyte Count <500 cells/mm^3, Absolute Neutrophil Count <1000 cells/mm^3, Hemoglobin <8 g/dL).
Conditional/Caution History of recurrent infections, chronic or localized active infection (avoid initiation), latent TB (must be treated first), history of malignancy, or significant cardiovascular risk factors (especially in adults aged 65 and older).

Age and Physiological State Rules

  • Age: Eligibility begins at a minimum of 2 years of age for specific juvenile conditions (e.g., pJIA) and 12 years of age for others (e.g., Atopic Dermatitis). Use in adults 65 is cautioned, especially with cardiovascular risk factors.
  • Pregnancy and Lactation: Use is not recommended during pregnancy due to potential fetal harm. Women of reproductive potential must use effective contraception during treatment and for a specified period after the final dose. Breastfeeding is not recommended.

What should I know about interactions with other medicines?

Rincu interactions are defined by the product's local action as an antacid, as documented in official government regulatory information. The primary concern is a pharmacokinetic interaction where co-administration causes a reduction in the systemic exposure of numerous other orally administered medicines. This occurs because Rincu's active ingredients, Calcium Carbonate and Magnesium Carbonate, elevate gastric pH and form insoluble complexes (chelation) with drugs like Tetracycline and Fluoroquinolone Antibiotics, Bisphosphonates, and Levothyroxine. This consistently leads to a decreased absorption and reduced efficacy of the co-administered drug.

To mitigate this effect, official regulatory labeling establishes a mandatory administration timing rule. Rincu and interacting oral medications require a separation of doses, often ranging from one to four hours, depending on the specific medicine.

A separate pharmacodynamic interaction is documented regarding the elemental components. Combining Rincu with other magnesium-containing preparations or Thiazide Diuretics can increase the body's exposure to the active ingredients. This heightened exposure poses a documented risk of hypermagnesaemia (elevated magnesium levels), which is specifically noted for the population with renal impairment due to reduced renal clearance. Additionally, an interaction is noted regarding Cardiac Glycosides (like Digoxin) due to the potential for arrhythmias stemming from increased calcium concentrations.

Mechanism of Action

How Rincu Works

Rincu operates through a localized and rapid chemical mechanism that directly targets the contents of the stomach rather than biological receptors or enzymes. The mechanism is defined by two core domains: direct neutralization and afferent signal dampening.

Direct Neutralization of Gastric Acidity

Rincu's action is initiated by the direct chemical neutralization of Hydrochloric Acid ( HCl) within the stomach lumen. The active carbonate salts rapidly dissolve and engage in an acid-base reaction that consumes HCl and elevates the surrounding gastric pH. This immediate chemical intervention reduces the concentration of corrosive H^+ ions contacting the esophageal and gastric lining, which results in a physiological change in the upper GI environment.

Buffering Synergy and Afferent Signal Dampening

The combination of Calcium Carbonate and Magnesium Carbonate provides a balanced buffering capacity, contributing to sustained pH modulation following the initial rapid neutralization. This essential physiological change removes the chemical stimulus from local chemosensitive receptors in the mucosa. By arresting the chemical irritation at its source, the mechanism effectively dampens the local nociceptive signaling that would otherwise transmit afferent signaling associated with mucosal irritation.

Dosage and Administration Information

How to Use Rincu — Official Administration Guidelines

Rincu is an oral medicine for which administration is governed by explicit rules detailing the method of intake, dose limits, and frequency. The general principle of use is symptom-driven (PRN), following a standardized protocol outlined in official labeling.


Administration Scope

Feature Guideline Explicitly Stated in Documentation
Route of administration Oral administration only.
Dosing schedule The typical single dose is 2 to 4 tablets. The maximum total dose is restricted to approximately 10 to 12 tablets over a 24-hour period.
Timing in relation to meals May be taken approximately one hour after meals or at bedtime, in addition to administration at the onset of symptoms.
Preparation requirements The tablet must be chewed completely before swallowing to ensure proper activation; it must not be swallowed whole.
Age-group administration Not recommended for use in children under 12 years of age.

Procedural Constraints

Constraint Requirement as per Official Labeling
Duration Limit Continuous self-treatment at the maximum dose should not exceed 14 days.
Drug Separation Administer at least 2 hours before or after taking other oral medications to prevent interference with absorption.

Connection to the Overall Use Protocol

Documentation structures the use of Rincu around its chewable form, establishing a mandatory chewing technique necessary for proper delivery of the active ingredients. The protocol defines a clear as-needed frequency with strictly defined maximum dose and duration limits to govern the medicine's proper use, ensuring procedural adherence.

Recent Clinical Evidence

Evidence Overview for Rincu

Rincu, a combination antacid containing Calcium Carbonate and Magnesium Carbonate, is supported by research that focuses on its rapid chemical action and short-term symptom management. The evidence is generally assessed within established regulatory frameworks for Over-the-Counter (OTC) medicines, consistent with standardized testing and regulatory acceptance.


Evidence for Acute Heartburn and Acid Indigestion

Research exploring antacids with this combination was studied for occasional heartburn (pyrosis) and acid indigestion using various methods, including short-term Randomized Controlled Trials (RCTs). The key research goal in these trials was to explore how symptoms changed over time, particularly when compared to a non-active substitute (placebo).

Studies applied in research contexts involving fluctuating symptoms monitored patient-reported outcomes and the time until perceived change. Data show patterns related to rapid chemical activity. Findings describe patterns observed in the studies related to short-term changes in physical discomfort associated with acute episodes.

Types of Studies Used to Confirm Acid Neutralization

The foundation of the evidence relies on objective physiological and chemical research. This includes in vitro (laboratory) studies that precisely measure the Acid-Neutralizing Capacity (ANC) and in vivo pharmacodynamic (PD) studies evaluated in humans. These studies monitor the change in pH (acidity level) inside the stomach. This research contributes to understanding the medicine's observed effect on temporary physiological imbalance.


Research on Duration, Populations, and Limitations

Most available evidence is derived from studies observing responses over defined time intervals that are typically very short, often focusing on single-dose administration. The evidence available explores acute changes measured during the study period.

Research was observed primarily in healthy adult volunteers or adults experiencing mild, occasional symptoms. Studies report that the results apply only to the populations studied. Data for certain groups, such as children, older adults, or pregnant individuals, remain insufficient from dedicated randomized trials. The studies were designed to research short-term symptom changes; there is limited data on how this medicine affects long-term outcomes or its role in preventing conditions.

Key Studies & References

  1. National Library of Medicine (NLM) - Drug Record: Calcium Carbonate and Magnesium Carbonate
  2. Evidence-Based Review of the Acid-Neutralizing Capacity (ANC) of Over-the-Counter Antacid Formulations

Frequently Asked Questions (FAQ)

Common questions about Rincu (FAQ)


Q: How long does it typically take to notice the effects of Rincu?

Studies indicate that Rincu's active ingredients begin working very quickly. In laboratory models simulating the stomach environment, the antacid action, which neutralizes acid and increases pH, was shown to begin within seconds of administration. This mechanism supports the product's fast-acting classification.


Q: Are there any common over-the-counter medicines that interact with Rincu?

Official product information indicates that antacids can interact with many other medicines. This includes certain over-the-counter drugs, as well as prescription medicines. For this reason, official documentation includes a statement encouraging consultation with a healthcare provider or pharmacist if other medications are being taken.


Q: Can older adults typically use Rincu safely?

Official drug facts advise individuals to consult a doctor before using Rincu if they have kidney disease. This is an important consideration for older adults, as kidney function often declines with age, increasing the risk of magnesium accumulation. Official labeling includes a warning statement encouraging consultation with a doctor regarding kidney function prior to use.


Q: Can I take Rincu if I have an existing kidney or liver condition?

Regulatory documents emphasize the importance of having a discussion with a doctor before using Rincu if you have kidney disease or are on a magnesium-restricted diet. The magnesium component in the medicine requires proper kidney function for safe elimination from the body. Official information suggests that all coexisting medical conditions, including liver conditions, should be disclosed to a healthcare provider.


Q: What is the expected duration of Rincu's action in the body?

Research indicates the action of Rincu is rapid and short-term. In simulated studies, the strong acid-neutralizing effect was observed to last for approximately one hour. This duration is consistent with its classification as an on-demand, acute symptom reliever.


Q: Are there any known long-term effects of taking Rincu?

Rincu is designed for acute, short-term symptom relief. Official warnings state that continuous use at the maximum recommended dosage is limited to two weeks, unless the medicine is being used under the direct advice and supervision of a doctor. Chronic overuse is associated with the risk of serious side effects.


Q: Can Rincu cause problems with blood pressure or heart rate?

Official safety warnings list serious cardiovascular effects that may occur from chronic, excessive use. These rare effects are linked to abnormally high levels of calcium or magnesium in the body. Symptoms include a slow heart rate or feeling light-headed. Regulatory information indicates these symptoms are serious and professional medical attention should be sought if they occur.


Q: What is the difference between Rincu and a placebo in clinical trials?

Clinical studies confirm Rincu's mechanism of action compared to a non-active substitute (placebo). In one laboratory study, Rincu quickly raised the simulated stomach pH to a level that can deactivate pepsin, an irritating enzyme, while the placebo did not. This data illustrates the chemical action of the active medicine versus the non-active substance.


Q: What are the most important things to tell a healthcare provider about before starting Rincu?

Regulatory documents clearly identify key conditions for consultation before starting Rincu. These include if you have kidney disease, are on a magnesium-restricted diet, or are currently taking any prescription drugs. Official labeling directs that a consultation is necessary when certain medical conditions or medications are present.


Q: What is the general consensus on Rincu's effectiveness in studies?

Studies and official documents indicate Rincu has fast-acting and strong acid-neutralizing properties. The effectiveness in symptom relief is tied to its ability to rapidly raise the pH level in the stomach. This evidence supports the product's function as an acute antacid.


Q: Will Rincu make me feel different or sleepy?

In rare cases of overuse, the accumulation of the active ingredients can lead to severe side effects that affect the nervous system. These documented effects include feelings of confusion and drowsiness. If these effects occur, stopping use and consulting a healthcare professional is advised by regulatory guidance.


Q: Can Rincu affect my ability to drive or operate machinery?

The official safety warnings associated with Rincu include the potential for confusion and drowsiness as symptoms of rare, serious side effects caused by excessive use. When these effects occur, official information suggests avoiding activities like driving or operating machinery.


Q: Why is Rincu sometimes referred to by a different name?

Rincu is the name for a combination product containing the two active ingredients: Calcium Carbonate and Magnesium Carbonate. These same active ingredients are sold under many different brand names by various manufacturers in the market.


Q: Is Rincu a controlled substance or addictive?

Rincu is regulated as an Over-the-Counter (OTC) medicine. Because of this classification, the medicine is not considered a controlled substance, and it does not have known addictive properties.


Q: Are there specific foods or drinks I need to avoid while taking Rincu?

Official drug information mentions a known interaction with food, specifically products high in calcium like milk or dairy. Long-term combination of Rincu with high amounts of milk products can lead to a serious metabolic condition called Milk-Alkali Syndrome. It may be beneficial to discuss your diet with a healthcare provider, particularly regarding consistent consumption of calcium-rich foods.


Q: How is Rincu thought to interact with alcohol?

Official drug information lists one known alcohol interaction for the active ingredients in Rincu. Official product information suggests that consultation with a healthcare provider regarding alcohol consumption is appropriate.


Q: Does Rincu have a known risk of causing skin reactions?

Official warnings state that signs of an allergic reaction are serious and should be reported to a healthcare provider immediately. These signs, documented in the labeling, include skin rash, itching, hives, or swelling.


Q: If Rincu is not working as expected, what is generally the next step?

Regulatory labeling provides specific guidance for when to stop use and seek professional medical advice. Regulatory labeling advises that if symptoms persist for more than two weeks, discontinuing use and consulting a doctor is appropriate.


Q: Does Rincu interact with herbal remedies like St. John's Wort?

Official documents state that antacids may interact with various non-prescription items. Because herbal remedies and supplements can affect the absorption of other medicines, official labeling suggests consultation with a healthcare provider or pharmacist before combining Rincu with any herbal products.


Q: What are the signs of a rare but serious side effect of Rincu?

Official warnings list specific signs of rare but serious side effects caused by the accumulation of active ingredients. These include increased thirst or urination, confusion, drowsiness, and slow heart rate. Regulatory guidance states that if these signs are noticed, stopping the use of Rincu and immediately consulting a doctor is necessary.


Q: Why is Rincu sometimes not recommended for individuals with certain allergies?

The product is officially not recommended for individuals with a known allergy or hypersensitivity. This includes allergies to the active ingredients (calcium carbonate) or to other components within the pill, such as specific dyes or preservatives.

How should Rincu be stored and disposed of?

The storage and disposal instructions for Rincu (Calcium Carbonate / Magnesium Carbonate chewable tablet) are defined by regulatory labeling to ensure product stability and safety.

Storage Requirements

Condition Regulatory Requirement
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep the medication in the original container, tightly closed, and protect from excess moisture and humidity.
Child Safety The product must be stored out of the reach of children.

Disposal Instructions

Unused or expired Rincu must be disposed of according to local regulations. Official guidelines state that the product should not be flushed down a toilet or poured down a drain. Consult a pharmacist or local waste disposal service for guidance on safely discarding expired or unwanted medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Rincu found in:

A-Z Index: